Factors effecting GIT absorbtion Flashcards

1
Q

For small molecule drugs, the X is the major site of absorption, regardless of the dominant ionization state (if applicable) of the molecule

A

For small molecule drugs, the small intestine is the major site of absorption, regardless of the dominant ionization state (if applicable) of the molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The stomach IS OR IS NOT a significant site of absorption
The large intestine IS OR IS NOT a significant site of absorption

A

The stomach is not a significant site of absorption
The large intestine is not a significant site of absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • Granules- ARE OR ARENT ABSORBED absorbed
  • Particles ARE OR ARENT absorbed
  • Molecules in solution
    Are absorbed
    Indeed, the API has to be in solution for it to be absorbed
A
  • Granules - Are not absorbed
  • Particles - Are not absorbed
  • Molecules in solution - Are absorbed

Indeed, the API has to be in solution for it to be absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Four physical factors which effect solubility and dissolution

A
  • Particle size/ SA
  • Physical form (amorphouse dissolves faster due to disordered structure and less structural stability than crystaline)
  • Hydration state of physical form - hydrated compounds have a more open structure, and lower lattice energy
  • Salt formation - it enhances solubility making it more polar so dissociates more readily in water
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define solubility and dissolution rate

A
  • Solubility: how much of an API will dissolve in a given volume of solvent at a given temperature
  • Dissolution rate: how fast does an API get into solution in a given volume of solvent at a given temperature
  • Although distinct, in general higher solubility leads to faster dissolution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Small particles = X surface area = X dissolution

A

Small particles = larger surface area = faster dissolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why are salts so commonly used in drugs

A
  • E.g. metformin hydrochloride, salbutamol sulfate, atorvastatin clacium
  • Salt formation increases ionisation and polarity, because ionic bonds interacts more with water
  • Dissolves faster and API has to be in solution to be absorbed
  • Salt is an ionised form of the drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why do we prefer drugs to be weak acids or weak bases in the GIT

A
  • The stomach is pH 1-3 while intestine pH 6-8. Weak acids and bases can exploit these to maximise absorption
  • Weak acids: exist in non ionised form in the stomach. So they pass through membranes faster
  • Weak bases: tend to be non ionised in the intestine. So absorbed more here
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why are more drugs weak bases than weak acids

A
  • Weak bases: tend to be non ionised in the intestine. So absorbed more here
  • Intestine has a larger surface area, so is the primary site of absorption
  • Because stomach has a small SA regardless of ionisation state very little absorption occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • Molecule needs to be in solution to be absorbed
  • Molecule needs to be unionised to be absorbed
  • But….
A
  • Molecule needs to be in solution to be absorbed
  • Molecule needs to be unionised to be absorbed
  • But….
  • Molecule might not be that soluble when unionised
  • Molecule might be unionised in the stomach, but not absorbed because of small surface area
  • Molecule might be ionised in the small intestine, but is still absorbed due to large surface area & equilibrium
  • Don’t think in absolutes ! (e.g. with Lipinski)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is an ‘acid labile’ drug

A
  • Low pH, ca. 1-3
  • Many drugs are “acid labile” i.e. they break down in acidic conditions, losing their activity as a result e.g.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does ‘enteric coating’ work

A
  • It is a special acid insoluble polymer coating the drug
  • It protects the API in acidic environments like the stomach - and protects stomach from API
  • The polymer only dissolves in higher pH environments of the small intestine
  • Dosage form stays intact until it has passed through the stomach
  • Due to more absorption/larger SA in SI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pH of the large intestine

A
  • pH 6.5-7.5
  • Not a major site for drug absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name a drug that targets large intestine

A
  • Aminosalicytes for IBD
  • Formulation needs to ensure API reaches colon intact
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe how mesalazine is designed for its function

A
  • Targets large intestine for anti-inflammatory action in IBD
  • Has a ‘eudragit’ coating - dissolves at pHs > 7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name two food common interactions

A
  • Tetracycline + calcium ions (e.g. milk) = insoluble complex and no absorption
  • Statins with grapefruit juice = increase risk of side FX
    Simvastatin = avoid
    Atorvastatin = avoid with large quantities of juice
  • Compounds in grapefruit juice inhibit GIT enzyme which breakdowns statins, increases bioavailability = overdose
17
Q

What is the overall transit time of drugs and what effects it

A
  • Varies with age (longer in elderly)
  • Varies with disease state, diet and GIT
  • Varies with medication e.g. loperamide slow transit
18
Q

First pass metabolism - what is it and what effects does it have

A
  • Anything absorbed from the GIT has the potential to undergo first pass metabolism
  • When a drug is metabolised in the liver before entering the bloodstream
  • It can be heavily metabolised in the liver so less released into blood so REDUCES BIOAVAILABILITY
19
Q

What are ways to avoid first pass metabolism

A
  • Sublingual
  • Inhalation
  • Transdermal
  • Injection
  • Buccal (cheek)